Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience
ConclusionsTotal-body PET/CT with an ultra-low dose of [18F]-FDG can maintain satisfactory image quality and lesion detectability in CRC.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Colorectal Cancer | Liver | Nuclear Medicine | Ovarian Cancer | Ovaries | PET Scan | Study | Urology & Nephrology | Women